Additionally, we have found further that the tumor promoting effects in leukocytes were abolished via inhibition of PLD through the use of small-molecule inhibitors specific for PLD, which we hypothesize indicates that the inflammatory PLD has a key role in breast cancer progression. This evidence concerns the gene GPLD1 and breast carcinoma.